发明授权
EP2099485B1 ALPHAVIRUS AND ALPHAVIRUS REPLICON PARTICLE FORMULATIONS AND METHODS 有权
ALPHAVIRUS和ALPHAVIRUS REPLICON颗粒制剂和方法

  • 专利标题: ALPHAVIRUS AND ALPHAVIRUS REPLICON PARTICLE FORMULATIONS AND METHODS
  • 专利标题(中): ALPHAVIRUS和ALPHAVIRUS REPLICON颗粒制剂和方法
  • 申请号: EP07844849.5
    申请日: 2007-11-02
  • 公开(公告)号: EP2099485B1
    公开(公告)日: 2018-03-21
  • 发明人: DEPAZ, Roberto A.TALARICO, Todd L.
  • 申请人: AlphaVax, Inc.
  • 申请人地址: 2 Triangle Drive Research Triangle Park, NC 27709-0307 US
  • 专利权人: AlphaVax, Inc.
  • 当前专利权人: AlphaVax, Inc.
  • 当前专利权人地址: 2 Triangle Drive Research Triangle Park, NC 27709-0307 US
  • 代理机构: FRKelly
  • 优先权: US864366P 20061103
  • 国际公布: WO2008058035 20080515
  • 主分类号: A61K39/12
  • IPC分类号: A61K39/12 A61K9/19 C12N15/86 C12N7/00 A61K39/00
ALPHAVIRUS AND ALPHAVIRUS REPLICON PARTICLE FORMULATIONS AND METHODS
摘要:
Disclosed are methods for preparing dried (preferably lyophilized) preparations comprising a population of alphaviruses or alphavirus replicon particles, a sugar or polyol, a surfactant and a salt and preparations made by said methods, both in the dried form but also as liquids prior to drying or after reconstituting dried preparations. These preparations may further comprise a plasticizer and/or a bulking agent. These preparations are readily reconstituted, with little or no loss in infectivity of the viruses or replicon particles.
信息查询
0/0